Literature DB >> 19965871

ATM augments nuclear stabilization of DYRK2 by inhibiting MDM2 in the apoptotic response to DNA damage.

Naoe Taira1, Hiroyuki Yamamoto, Tomoko Yamaguchi, Yoshio Miki, Kiyotsugu Yoshida.   

Abstract

The tumor suppressor p53 is a transcription factor that regulates cell cycle, DNA repair, senescence, and apoptosis in response to DNA damage. Phosphorylation of p53 at Ser-46 is indispensable for the commitment to apoptotic cell death. A previous study has shown that upon exposure to genotoxic stress, DYRK2 translocates into the nucleus and phosphorylates p53 at Ser-46, thereby inducing apoptosis. However, less is known about mechanisms responsible for intracellular control of DYRK2. Here we show the functional nuclear localization signal at N-terminal domain of DYRK2. Under normal conditions, nuclear and not cytoplasmic DYRK2 is ubiquitinated by MDM2, resulting in its constitutive degradation. In the presence of proteasome inhibitors, we detected a stable complex of DYRK2 with MDM2 at the nucleus. Upon exposure to genotoxic stress, ATM phosphorylates DYRK2 at Thr-33 and Ser-369, which enables DYRK2 to escape from degradation by dissociation from MDM2 and to induce the kinase activity toward p53 at Ser-46 in the nucleus. These findings indicate that ATM controls stability and pro-apoptotic function of DYRK2 in response to DNA damage.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19965871      PMCID: PMC2836095          DOI: 10.1074/jbc.M109.042341

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  A genome-wide Drosophila RNAi screen identifies DYRK-family kinases as regulators of NFAT.

Authors:  Yousang Gwack; Sonia Sharma; Julie Nardone; Bogdan Tanasa; Alina Iuga; Sonal Srikanth; Heidi Okamura; Diana Bolton; Stefan Feske; Patrick G Hogan; Anjana Rao
Journal:  Nature       Date:  2006-03-01       Impact factor: 49.962

2.  MDM2-regulated degradation of HIPK2 prevents p53Ser46 phosphorylation and DNA damage-induced apoptosis.

Authors:  Cinzia Rinaldo; Andrea Prodosmo; Francesca Mancini; Stefano Iacovelli; Ada Sacchi; Fabiola Moretti; Silvia Soddu
Journal:  Mol Cell       Date:  2007-03-09       Impact factor: 17.970

3.  BRCA1-mediated ubiquitination inhibits topoisomerase II alpha activity in response to oxidative stress.

Authors:  Hirokuni Shinagawa; Yoshio Miki; Kiyotsugu Yoshida
Journal:  Antioxid Redox Signal       Date:  2008-05       Impact factor: 8.401

4.  Role for DYRK family kinases on regulation of apoptosis.

Authors:  Kiyotsugu Yoshida
Journal:  Biochem Pharmacol       Date:  2008-07-02       Impact factor: 5.858

5.  The deubiquitinating enzyme USP11 controls an IkappaB kinase alpha (IKKalpha)-p53 signaling pathway in response to tumor necrosis factor alpha (TNFalpha).

Authors:  Tomoko Yamaguchi; Junko Kimura; Yoshio Miki; Kiyotsugu Yoshida
Journal:  J Biol Chem       Date:  2007-09-26       Impact factor: 5.157

Review 6.  Nuclear trafficking of pro-apoptotic kinases in response to DNA damage.

Authors:  Kiyotsugu Yoshida
Journal:  Trends Mol Med       Date:  2008-06-06       Impact factor: 11.951

7.  Protein kinase C delta activates IkappaB-kinase alpha to induce the p53 tumor suppressor in response to oxidative stress.

Authors:  Tomoko Yamaguchi; Yoshio Miki; Kiyotsugu Yoshida
Journal:  Cell Signal       Date:  2007-06-21       Impact factor: 4.315

8.  Protein kinase C delta induces transcription of the TP53 tumor suppressor gene by controlling death-promoting factor Btf in the apoptotic response to DNA damage.

Authors:  Hanshao Liu; Zheng-Guang Lu; Yoshio Miki; Kiyotsugu Yoshida
Journal:  Mol Cell Biol       Date:  2007-10-15       Impact factor: 4.272

9.  NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21.

Authors:  Joseph R Arron; Monte M Winslow; Alberto Polleri; Ching-Pin Chang; Hai Wu; Xin Gao; Joel R Neilson; Lei Chen; Jeremy J Heit; Seung K Kim; Nobuyuki Yamasaki; Tsuyoshi Miyakawa; Uta Francke; Isabella A Graef; Gerald R Crabtree
Journal:  Nature       Date:  2006-03-22       Impact factor: 49.962

10.  A functional genome-wide RNAi screen identifies TAF1 as a regulator for apoptosis in response to genotoxic stress.

Authors:  Junko Kimura; Su Tien Nguyen; Hanshao Liu; Naoe Taira; Yoshio Miki; Kiyotsugu Yoshida
Journal:  Nucleic Acids Res       Date:  2008-08-06       Impact factor: 16.971

View more
  32 in total

1.  DYRK2 priming phosphorylation of c-Jun and c-Myc modulates cell cycle progression in human cancer cells.

Authors:  Naoe Taira; Rei Mimoto; Morito Kurata; Tomoko Yamaguchi; Masanobu Kitagawa; Yoshio Miki; Kiyotsugu Yoshida
Journal:  J Clin Invest       Date:  2012-02-06       Impact factor: 14.808

2.  Acetylation-dependent regulation of MDM2 E3 ligase activity dictates its oncogenic function.

Authors:  Naoe T Nihira; Kohei Ogura; Kouhei Shimizu; Brian J North; Jinfang Zhang; Daming Gao; Hiroyuki Inuzuka; Wenyi Wei
Journal:  Sci Signal       Date:  2017-02-14       Impact factor: 8.192

Review 3.  Alterations in the nucleocytoplasmic transport in apoptosis: Caspases lead the way.

Authors:  Gelina S Kopeina; Evgeniia A Prokhorova; Inna N Lavrik; Boris Zhivotovsky
Journal:  Cell Prolif       Date:  2018-06-26       Impact factor: 6.831

4.  CHK2 stability is regulated by the E3 ubiquitin ligase SIAH2.

Authors:  C García-Limones; M Lara-Chica; C Jiménez-Jiménez; M Pérez; P Moreno; E Muñoz; M A Calzado
Journal:  Oncogene       Date:  2016-01-11       Impact factor: 9.867

5.  Identification of early gene expression changes in primary cultured neurons treated with topoisomerase I poisons.

Authors:  Sharyn L Rossi; Casey J Lumpkin; Ashlee W Harris; Jennifer Holbrook; Cinsley Gentillon; Suzanne M McCahan; Wenlan Wang; Matthew E R Butchbach
Journal:  Biochem Biophys Res Commun       Date:  2016-09-15       Impact factor: 3.575

6.  Splice variants of the dual specificity tyrosine phosphorylation-regulated kinase 4 (DYRK4) differ in their subcellular localization and catalytic activity.

Authors:  Chrisovalantis Papadopoulos; Krisztina Arato; Eva Lilienthal; Johannes Zerweck; Mike Schutkowski; Nicolas Chatain; Gerhard Müller-Newen; Walter Becker; Susana de la Luna
Journal:  J Biol Chem       Date:  2010-12-02       Impact factor: 5.157

7.  Exploring the link between germline and somatic genetic alterations in breast carcinogenesis.

Authors:  Núria Bonifaci; Bohdan Górski; Bartlomiej Masojć; Dominika Wokołorczyk; Anna Jakubowska; Tadeusz Dębniak; Antoni Berenguer; Jordi Serra Musach; Joan Brunet; Joaquín Dopazo; Steven A Narod; Jan Lubiński; Conxi Lázaro; Cezary Cybulski; Miguel Angel Pujana
Journal:  PLoS One       Date:  2010-11-22       Impact factor: 3.240

8.  The Many Faces of MDM2 Binding Partners.

Authors:  Maurisa F Riley; Guillermina Lozano
Journal:  Genes Cancer       Date:  2012-03

9.  FUS is phosphorylated by DNA-PK and accumulates in the cytoplasm after DNA damage.

Authors:  Qiudong Deng; Christopher J Holler; Georgia Taylor; Kathryn F Hudson; William Watkins; Marla Gearing; Daisuke Ito; Melissa E Murray; Dennis W Dickson; Nicholas T Seyfried; Thomas Kukar
Journal:  J Neurosci       Date:  2014-06-04       Impact factor: 6.167

10.  Dyrk2-associated EDD-DDB1-VprBP E3 ligase inhibits telomerase by TERT degradation.

Authors:  Hae-Yun Jung; Xin Wang; Sohee Jun; Jae-Il Park
Journal:  J Biol Chem       Date:  2013-01-28       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.